The global regenerative medicine market has witnessed a remarkable growth in the past few years. The US holds the largest share in the market as a large number of people in the country suffer from various kinds of chronic and infectious diseases. According to “Global Regenerative Medicine Market”, the latest research report by RNCOS, regenerative medicine offers a ray of hope to medical communities and governments across the globe to cut down expenses. With around US$ 4 Billion size, the US regenerative medicine market is expected to witness further growth in revenues.
Backed by factors, such as huge R&D investment and increasing aging population worldwide, the global regenerative medicine market reached the mark of US$ 7.2 Billion in 2010. In future, the market will be characterized by the presence of innovative products and rising level of awareness. Overall, significant developments will create a strong demand for stem cell-based therapies and tissue-engineered products in the regenerative process.
The report identifies and analyzes key developments, including important drivers and challenges confronted by the regenerative medicine market. It not only covers possible growth areas in terms of future outlook for major industry segments and therapies in the R&D pipeline, but also provides an insight into stem cell therapy and tissue engineering sectors. The study, an outcome of an extensive research and in-depth analysis of the global regenerative medicine market, discusses forecast in key areas, and describes briefly the developments associated with active market players so that clients could get a clear picture of the regenerative medicine sector.
|
